News from the FDA/CDC

News from the FDA/CDC

FDA OKs new treatment for erosive esophagitis

Vonoprazan provides clinicians with a “new first-in-class therapeutic option that demonstrated faster healing in the more difficult-to-treat GERD...

News from the FDA/CDC

FDA approves subcutaneous infliximab for IBD

The new formulation was approved based on phase 3 pivotal trials that evaluated the safety and efficacy of infliximab-dyyb as maintenance therapy...

News from the FDA/CDC

New meningococcal vaccine wins FDA approval

The vaccine “has the potential to protect more adolescents and young adults from this severe and unpredictable disease by providing the broadest...

Pages